Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-05-05 @ 3:20 PM
Study NCT ID:
NCT01030718
Status:
COMPLETED
Last Update Posted:
2010-12-14
First Post:
2009-12-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rollover Study of BMS-354825 in Patients With CML and Ph+ALL
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA180-036
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb